Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Bioline RX(BLRX) the Revenue is 294 K (-3.29%), Miss estimate;the EBIT is -3.573 M (-55.15%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.00B3.29%
0.00B64.47%
-0.00B67.76%
EBITMiss expectations
-0.00B55.15%
-0.00B29.27%
-0.00B25.88%
EPS
TBA--
0--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf